Our healthcare partner Roivant Sciences, a pharmaceutical company based in Basel, is launching Genevant with the Canadian Arbutus Biopharma Corporation. The aim of the new…
Big Pharma's billion-dollar scramble to invest in start-ups to fuel innovation The worldwide prescription drug market is growing at 6.5% compounded annually and is expected…
Basel-based venture capitalist firm BioMedPartners has closed its new venture capital fund BioMedInvest III at 100 million Swiss francs. The fund will help drive growth…
A short review A year ago, BaselArea.swiss presented BaseLaunch at a fully booked launch event in Basel, Switzerland. Guests from the healthcare industry, research, academia…
The pharma company Santhera Pharmaceuticals has obtained the worldwide exclusive license for the product candidate POL6014. Developed by Polyphor, the drug has the potential to…